Low-Level Laser Therapy Induces Melanoma Tumor Growth by Promoting Angiogenesis

The effects of low-level laser therapy (LLLT) on tumor growth are inconsistent. In this study, we investigated the effects of LLLT on melanoma tumor growth and angiogenesis. C57/BL6 mice were challenged with B16F10 melanoma cells and treated with LLLT for 5 consecutive days; untreated mice were used...

Full description

Bibliographic Details
Main Authors: Yi-Yuan Lin, Shin-Yi Lee, Yu-Jung Cheng
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/13/2/320
_version_ 1797619853460242432
author Yi-Yuan Lin
Shin-Yi Lee
Yu-Jung Cheng
author_facet Yi-Yuan Lin
Shin-Yi Lee
Yu-Jung Cheng
author_sort Yi-Yuan Lin
collection DOAJ
description The effects of low-level laser therapy (LLLT) on tumor growth are inconsistent. In this study, we investigated the effects of LLLT on melanoma tumor growth and angiogenesis. C57/BL6 mice were challenged with B16F10 melanoma cells and treated with LLLT for 5 consecutive days; untreated mice were used as controls. Tumor weight, angiogenesis, immunohistochemistry, and protein levels were compared between the treated and untreated mice. In an in vitro experiment, B16F10 cells were treated with LLLT. Proteins were extracted and subjected to Western blot analysis for analyzing signaling pathways. Compared with the findings in the untreated mice, tumor weight substantially increased in the treated mice. Both immunohistochemical and Western blot analyses revealed markedly increased levels of CD31, a biomarker of vascular differentiation, in the LLLT group. In B16F10 cells, LLLT considerably induced the phosphorylation of extracellular signal-regulated kinase (ERK), which, in turn, phosphorylated p38 mitogen-activated protein kinase (MAPK). Furthermore, LLLT induced the expression of vascular endothelial growth factor, but not hypoxia-inducible factor-1α, through the ERK/p38 MAKP signaling pathways. Our findings indicate that LLLT induces melanoma tumor growth by promoting angiogenesis. Therefore, it should be avoided in patients with melanoma.
first_indexed 2024-03-11T08:33:52Z
format Article
id doaj.art-ae3f3acfa465494da5bb61310023b368
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-11T08:33:52Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-ae3f3acfa465494da5bb61310023b3682023-11-16T21:39:38ZengMDPI AGLife2075-17292023-01-0113232010.3390/life13020320Low-Level Laser Therapy Induces Melanoma Tumor Growth by Promoting AngiogenesisYi-Yuan Lin0Shin-Yi Lee1Yu-Jung Cheng2Department of Exercise and Health Science, National Taipei University of Nursing and Health Sciences, Taipei 112303, TaiwanGeneral Education Center, China Medical University, Taichung 406, TaiwanDepartment of Physical Therapy and Graduate Institute of Rehabilitation Science, China Medical University, Taichung 406, TaiwanThe effects of low-level laser therapy (LLLT) on tumor growth are inconsistent. In this study, we investigated the effects of LLLT on melanoma tumor growth and angiogenesis. C57/BL6 mice were challenged with B16F10 melanoma cells and treated with LLLT for 5 consecutive days; untreated mice were used as controls. Tumor weight, angiogenesis, immunohistochemistry, and protein levels were compared between the treated and untreated mice. In an in vitro experiment, B16F10 cells were treated with LLLT. Proteins were extracted and subjected to Western blot analysis for analyzing signaling pathways. Compared with the findings in the untreated mice, tumor weight substantially increased in the treated mice. Both immunohistochemical and Western blot analyses revealed markedly increased levels of CD31, a biomarker of vascular differentiation, in the LLLT group. In B16F10 cells, LLLT considerably induced the phosphorylation of extracellular signal-regulated kinase (ERK), which, in turn, phosphorylated p38 mitogen-activated protein kinase (MAPK). Furthermore, LLLT induced the expression of vascular endothelial growth factor, but not hypoxia-inducible factor-1α, through the ERK/p38 MAKP signaling pathways. Our findings indicate that LLLT induces melanoma tumor growth by promoting angiogenesis. Therefore, it should be avoided in patients with melanoma.https://www.mdpi.com/2075-1729/13/2/320melanomatumor growthangiogenesislow-level laser therapy
spellingShingle Yi-Yuan Lin
Shin-Yi Lee
Yu-Jung Cheng
Low-Level Laser Therapy Induces Melanoma Tumor Growth by Promoting Angiogenesis
Life
melanoma
tumor growth
angiogenesis
low-level laser therapy
title Low-Level Laser Therapy Induces Melanoma Tumor Growth by Promoting Angiogenesis
title_full Low-Level Laser Therapy Induces Melanoma Tumor Growth by Promoting Angiogenesis
title_fullStr Low-Level Laser Therapy Induces Melanoma Tumor Growth by Promoting Angiogenesis
title_full_unstemmed Low-Level Laser Therapy Induces Melanoma Tumor Growth by Promoting Angiogenesis
title_short Low-Level Laser Therapy Induces Melanoma Tumor Growth by Promoting Angiogenesis
title_sort low level laser therapy induces melanoma tumor growth by promoting angiogenesis
topic melanoma
tumor growth
angiogenesis
low-level laser therapy
url https://www.mdpi.com/2075-1729/13/2/320
work_keys_str_mv AT yiyuanlin lowlevellasertherapyinducesmelanomatumorgrowthbypromotingangiogenesis
AT shinyilee lowlevellasertherapyinducesmelanomatumorgrowthbypromotingangiogenesis
AT yujungcheng lowlevellasertherapyinducesmelanomatumorgrowthbypromotingangiogenesis